An elaborate DNA origami tubular nanodevice encapsulating antigens and adjuvants protects mice from cancer through tumour-specific immunomodulation.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Hollingsworth, R. E. & Jansen, K. NPJ Vaccines 4, 7 (2019).
Van der Burg, S. H. et al. Nat. Rev. Cancer 16, 219–233 (2016).
Smith, C. C. et al. Nat. Rev. Cancer 19, 465–478 (2019).
Anguille, S. et al. Leukemia 26, 2186–2196 (2012).
Kranz, L. M. et al. Nature 534, 396–401 (2016).
Liu, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-020-0793-6 (2020).
Jiang, Q. et al. Adv. Mater. 31, e1804785 (2019).
Wang, P. F. et al. Chem 2, 359–382 (2017).
Lu, Y., Aimetti, A. A., Langer, R. & Gu, Z. Nat. Rev. Mater. 1, 16075 (2016).
Ott, P. A. et al. Nature 547, 217–221 (2017).
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Li, H., Gu, Z. Nanodevices for cancer vaccination. Nat. Mater. 20, 286–287 (2021). https://doi.org/10.1038/s41563-021-00941-4